_oksvol_ - FACEIT level 10, 2,450 ELO

Germany
On FACEIT since 2024 146 matches tracked 105 matches in 30 days
ELO ▲ 740
2,450
30-day peak: 2,475
Rank EU
#67,243
Germany #1,718 in Germany
Last updated:

_oksvol_ at a glance

Level 10 2,450 ELO best map Ancient (58%)
2,250-2,499 ELO

Last 20 matches compared with 2,995 players in this group: K/R, ADR and win rate below average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 29%
0.97
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.30 ConsistencyShare of matches with a rating of 0.90 or higher. 55%
K/R
0.69
better than 27% of players
2,250-2,499 ELO avg: 0.74
Last 12 months
ADR
74.8
better than 21% of players
2,250-2,499 ELO avg: 80.8
Last 12 months
Win rate
45%
better than 28% of players
2,250-2,499 ELO avg: 50%
Last 12 months

Facts

25 ELO Next goal About one win is enough.
4 W · 3 L Best day +56 ELO · Nov 11, 2026
9 W · 6 L Overtime in overtime
Mirage Favorite map 54 of 146 matches
Ancient 58% Map pool tip weakest: Nuke 42%
2 knife kills Rare kills last 90 days
On Mondays Best time 64% win rate vs. 54%
FormMapsTiming

25 ELO away from the recorded peak (2,475). About one win is enough. 4:3 on Nov 11, 2026 (+56 ELO, last 90 days). 15 matches in overtime, 9 of them won (last 90 days). Most played: Mirage (54 of 146 matches). Strongest map: Ancient (58% win rate, 12 matches). Weakest: Nuke (42%, 12 matches). 2 knife kills (last 90 days). Best results on Mondays: 64% win rate vs. 54% overall (22 matches).

About _oksvol_

_oksvol_ plays CS2 on FACEIT level 10 with 2,450 ELO. The stats cover 146 matches. The strongest map is Ancient with a 58% win rate in 12 matches. Most played: Mirage with 54 matches and a 57% win rate. Biggest strength: Deaths per round at just 68% (lower is better), better than 87% of level 10 · 2,250-2,499 ELO players. Last 20 matches: 9 wins, 11 losses, -42 ELO. _oksvol_ does best on Mondays: 64% win rate in 22 matches.